Hub Cures Bi-weekly Speakers Series

Tuesdays 5 PM April 27-July 13

HUB CURES hosts bi-weekly speakers in the lead-up to MALSI+ 2021, the Commonwealth’s flagship networking event for life sciences startups and innovation.  Join with scientific innovators, entrepreneurs, business leaders and investors in this engaging series spotlighting how Massachusetts universities are leading the nation in bringing translation science to market. 

All Events are virtual on Tuesday evenings. General Schedule:

5 PM Networking

5:15-6:00 Program

6:00 Networking

Calendar at a Glance:

April 27:  Curt Carlson, WPI Trustee & former President of SRI International

May 11: Nabiha Saklayen, Co-Founder & CEO at Cellino

**Register for the Event

May 25: Kim Lewis, University Distinguished Professor of Biology at Northeastern University

June 8: Jeffrey Karp, Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School

June 22: Catherine Klapperich Professor and Vice Chair, Department of Biomedical Engineering, Boston University, and Peter H. Reinhart Founding Director, Institute for Applied Life Sciences, University of Massachusetts Amherst

July 13: Todd R. Golub, Director Broad Institute, MIT

Hub Cures May 11

May 11: Nabiha Saklayen on the Lab to Market Journey

Nabiha Saklayen co-founded Cellino Biotech, a personalized regenerative medicine company that is developing an AI-guided laser editing platform for autologous cell-based therapies--making these therapies scalable for the first time. The startup recently raised a $16M seed round led by The Engine and Khosla Ventures.  Full Bio

Jennifer Griffin develops and manages the investment strategy for initiatives and partnerships with the life sciences industry, at MLSC. She began her career in technology licensing at MIT. Full Bio

Hub Cures May 25

May 25: Kim Lewis on Solutions for Antibiotic Resistant Bacteria

Kim Lewis is one of the foremost scientists tackling Lyme disease. His 2015 published report in Antimicrobial Agents and Chemotherapy confirmed GLA/Johns Hopkins findings that the bacterium that causes Lyme disease forms dormant persister cells, which are known to survive antibiotics. He identified compounds for eliminating persister bacteria, and is also investigating the role of the microbiome in chronic Lyme disease. Full Bio

Joel Bressler manages relationships with the University’s spin-out businesses for the Center for Research Innovation. He's responsible for developing educational, informational, consulting, and other resources for these ventures and entrepreneurial research labs. Full Bio

Hub Cures May 25

June 8: Jeffrey Karp on the Importance of Iteration in Innovation

Jeffrey Karp is Brigham and Women’s Hospital Distinguished Chair in Clinical Anesthesiology, Perioperative and Pain Medicine, and Professor of Anesthesia at Harvard Medical School in Boston. He works in the fields of drug delivery, medical devices, stem cell therapeutics, and tissue adhesives; and is additionally on the faculty at the Harvard Stem Cell Institute, the Broad Institute, and at the Harvard-MIT Division of Health Sciences and Technology. Full Bio

Jenny Ro is CEO and Co-founder at Curious Reactor, a SaaS platform making human connections that matter. She's a scientist entrepreneur who has commercialized her own invention without a patent. Full Bio

Hub Cures May 25

June 22: Catherine Klapperich and Peter H. Reinhart on COVID-19 Testing at Universities

Catherine Klapperich is Director of the NIBIB POCTRN Center for Future Technologies in Cancer Care (CFTCC) at Boston University, and Director of the Laboratory for Diagnostics and Global Healthcare Technologies. Her research focuses on engineering medical devices for use in low-resource settings and at the point of care. Full Bio

Peter H. Reinhart is Founding Director, Institute for Applied Life Sciences, University of Massachusetts Amherst. He has more than 20 years of R&D management experience in the neuroscience and orphan disease space. He has led drug discovery programs in academia, biotechnology, and large Pharma. Full bio

Karen Utgoff serves as Director of IALS Venture Development Programs and the Site Director for I-Corps at UMass Amherst, bringing more than 25 years of experience to these roles. Full bio

April 27: Curt Carlson on the Practice of Innovation

Curtis R. Carlson, Ph.D., is a pioneer in the development and use of innovation best practices and an evangelist for innovation, education, and economic development, sharing best practices with government agencies, businesses, and foundations around the world. See his Bio

MALSI + 2021 Sponsors

Platinum: MassBio

Gold: Massachusetts Life Science Center, Troutman Pepper, Bayer

Silver: McDermott, Will & Emery; Burns Levinson

Supporter: ENET, Johnson & Johnson, Explora Biolabs